Brief Report - (2026) Volume 16, Issue 1
Received: 01-Jan-2026, Manuscript No. jccr-26-188948;
Editor assigned: 05-Jan-2026, Pre QC No. P-188948;
Reviewed: 19-Jan-2026, QC No. Q-188948;
Revised: 22-Jan-2026, Manuscript No. R-188948;
Published:
29-Jan-2026
, DOI: 10.37421/2165-7920.2026.16.1701
Citation: Martinez, Sofia. ”Syncope: A Silent Myocardial Infarction’s Hidden Signal.” J Clin Case Rep 16 (2026):1701.
Copyright: © 2026 Martinez S. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Syncope, a transient and self-limiting loss of consciousness, is a common clinical presentation that often necessitates a thorough investigation to identify its underlying cause. While many cases are benign, a significant proportion can be indicative of serious underlying pathology, particularly cardiac conditions. Among these, silent myocardial infarction (MI) has emerged as a critical consideration, especially in certain patient demographics, where it may manifest without the typical anginal symptoms [1].
Recognizing syncope as a potential harbinger of cardiac ischemia, even in the absence of chest pain, is paramount for timely diagnosis and intervention [2].
The diagnostic landscape of syncope is complex, and the focus on identifying cardiac etiologies remains a cornerstone of effective patient management [6].
This is particularly true when considering acute coronary syndromes, where syncope can be the sole or predominant symptom, posing significant diagnostic challenges [3].
Furthermore, specific types of MI, such as non-ST-elevation myocardial infarction (NSTEMI), can present atypically with syncope, underscoring the need for comprehensive cardiac workups [4].
The evaluation of unexplained syncope must include a high index of suspicion for silent MI, especially in individuals with pre-existing cardiovascular risk factors, as it can be a consequence of silent myocardial ischemia [5].
The prevalence and prognostic significance of silent MI in patients with unexplained syncope highlight the necessity of a thorough cardiac assessment, irrespective of the presence of typical anginal symptoms [5].
Moreover, myocardial infarction with non-obstructive coronary arteries (MINOCA) can also present with syncope, demanding its inclusion in the differential diagnosis when initial evaluations are inconclusive [7].
Risk stratification in patients experiencing syncope is crucial for identifying those at high risk of cardiac causes, including silent MI, guiding subsequent diagnostic strategies [8].
The management of silent MI, while differing from overt MI, carries significant prognostic implications, necessitating aggressive secondary prevention measures [9].
In the elderly population, syncope can be a particularly important sentinel event for silent MI, presenting unique diagnostic and management challenges due to atypical presentations [10].
Syncope, a transient and self-limiting loss of consciousness, is a common clinical presentation that often necessitates a thorough investigation to identify its underlying cause. While many cases are benign, a significant proportion can be indicative of serious underlying pathology, particularly cardiac conditions. Among these, silent myocardial infarction (MI) has emerged as a critical consideration, especially in certain patient demographics, where it may manifest without the typical anginal symptoms [1].
Recognizing syncope as a potential harbinger of cardiac ischemia, even in the absence of chest pain, is paramount for timely diagnosis and intervention [2].
The diagnostic landscape of syncope is complex, and the focus on identifying cardiac etiologies remains a cornerstone of effective patient management [6].
This is particularly true when considering acute coronary syndromes, where syncope can be the sole or predominant symptom, posing significant diagnostic challenges [3].
Furthermore, specific types of MI, such as non-ST-elevation myocardial infarction (NSTEMI), can present atypically with syncope, underscoring the need for comprehensive cardiac workups [4].
The evaluation of unexplained syncope must include a high index of suspicion for silent MI, especially in individuals with pre-existing cardiovascular risk factors, as it can be a consequence of silent myocardial ischemia [5].
The prevalence and prognostic significance of silent MI in patients with unexplained syncope highlight the necessity of a thorough cardiac assessment, irrespective of the presence of typical anginal symptoms [5].
Moreover, myocardial infarction with non-obstructive coronary arteries (MINOCA) can also present with syncope, demanding its inclusion in the differential diagnosis when initial evaluations are inconclusive [7].
Risk stratification in patients experiencing syncope is crucial for identifying those at high risk of cardiac causes, including silent MI, guiding subsequent diagnostic strategies [8].
The management of silent MI, while differing from overt MI, carries significant prognostic implications, necessitating aggressive secondary prevention measures [9].
In the elderly population, syncope can be a particularly important sentinel event for silent MI, presenting unique diagnostic and management challenges due to atypical presentations [10].
Syncope, a transient and self-limiting loss of consciousness, is a common clinical presentation that often necessitates a thorough investigation to identify its underlying cause. While many cases are benign, a significant proportion can be indicative of serious underlying pathology, particularly cardiac conditions. Among these, silent myocardial infarction (MI) has emerged as a critical consideration, especially in certain patient demographics, where it may manifest without the typical anginal symptoms [1].
Recognizing syncope as a potential harbinger of cardiac ischemia, even in the absence of chest pain, is paramount for timely diagnosis and intervention [2].
The diagnostic landscape of syncope is complex, and the focus on identifying cardiac etiologies remains a cornerstone of effective patient management [6].
This is particularly true when considering acute coronary syndromes, where syncope can be the sole or predominant symptom, posing significant diagnostic challenges [3].
Furthermore, specific types of MI, such as non-ST-elevation myocardial infarction (NSTEMI), can present atypically with syncope, underscoring the need for comprehensive cardiac workups [4].
The evaluation of unexplained syncope must include a high index of suspicion for silent MI, especially in individuals with pre-existing cardiovascular risk factors, as it can be a consequence of silent myocardial ischemia [5].
The prevalence and prognostic significance of silent MI in patients with unexplained syncope highlight the necessity of a thorough cardiac assessment, irrespective of the presence of typical anginal symptoms [5].
Moreover, myocardial infarction with non-obstructive coronary arteries (MINOCA) can also present with syncope, demanding its inclusion in the differential diagnosis when initial evaluations are inconclusive [7].
Risk stratification in patients experiencing syncope is crucial for identifying those at high risk of cardiac causes, including silent MI, guiding subsequent diagnostic strategies [8].
The management of silent MI, while differing from overt MI, carries significant prognostic implications, necessitating aggressive secondary prevention measures [9].
In the elderly population, syncope can be a particularly important sentinel event for silent MI, presenting unique diagnostic and management challenges due to atypical presentations [10].
Syncope, a transient and self-limiting loss of consciousness, is a common clinical presentation that often necessitates a thorough investigation to identify its underlying cause. While many cases are benign, a significant proportion can be indicative of serious underlying pathology, particularly cardiac conditions. Among these, silent myocardial infarction (MI) has emerged as a critical consideration, especially in certain patient demographics, where it may manifest without the typical anginal symptoms [1].
Recognizing syncope as a potential harbinger of cardiac ischemia, even in the absence of chest pain, is paramount for timely diagnosis and intervention [2].
The diagnostic landscape of syncope is complex, and the focus on identifying cardiac etiologies remains a cornerstone of effective patient management [6].
This is particularly true when considering acute coronary syndromes, where syncope can be the sole or predominant symptom, posing significant diagnostic challenges [3].
Furthermore, specific types of MI, such as non-ST-elevation myocardial infarction (NSTEMI), can present atypically with syncope, underscoring the need for comprehensive cardiac workups [4].
The evaluation of unexplained syncope must include a high index of suspicion for silent MI, especially in individuals with pre-existing cardiovascular risk factors, as it can be a consequence of silent myocardial ischemia [5].
The prevalence and prognostic significance of silent MI in patients with unexplained syncope highlight the necessity of a thorough cardiac assessment, irrespective of the presence of typical anginal symptoms [5].
Moreover, myocardial infarction with non-obstructive coronary arteries (MINOCA) can also present with syncope, demanding its inclusion in the differential diagnosis when initial evaluations are inconclusive [7].
Risk stratification in patients experiencing syncope is crucial for identifying those at high risk of cardiac causes, including silent MI, guiding subsequent diagnostic strategies [8].
The management of silent MI, while differing from overt MI, carries significant prognostic implications, necessitating aggressive secondary prevention measures [9].
In the elderly population, syncope can be a particularly important sentinel event for silent MI, presenting unique diagnostic and management challenges due to atypical presentations [10].
Syncope, a transient and self-limiting loss of consciousness, is a common clinical presentation that often necessitates a thorough investigation to identify its underlying cause. While many cases are benign, a significant proportion can be indicative of serious underlying pathology, particularly cardiac conditions. Among these, silent myocardial infarction (MI) has emerged as a critical consideration, especially in certain patient demographics, where it may manifest without the typical anginal symptoms [1].
Recognizing syncope as a potential harbinger of cardiac ischemia, even in the absence of chest pain, is paramount for timely diagnosis and intervention [2].
The diagnostic landscape of syncope is complex, and the focus on identifying cardiac etiologies remains a cornerstone of effective patient management [6].
This is particularly true when considering acute coronary syndromes, where syncope can be the sole or predominant symptom, posing significant diagnostic challenges [3].
Furthermore, specific types of MI, such as non-ST-elevation myocardial infarction (NSTEMI), can present atypically with syncope, underscoring the need for comprehensive cardiac workups [4].
The evaluation of unexplained syncope must include a high index of suspicion for silent MI, especially in individuals with pre-existing cardiovascular risk factors, as it can be a consequence of silent myocardial ischemia [5].
The prevalence and prognostic significance of silent MI in patients with unexplained syncope highlight the necessity of a thorough cardiac assessment, irrespective of the presence of typical anginal symptoms [5].
Moreover, myocardial infarction with non-obstructive coronary arteries (MINOCA) can also present with syncope, demanding its inclusion in the differential diagnosis when initial evaluations are inconclusive [7].
Risk stratification in patients experiencing syncope is crucial for identifying those at high risk of cardiac causes, including silent MI, guiding subsequent diagnostic strategies [8].
The management of silent MI, while differing from overt MI, carries significant prognostic implications, necessitating aggressive secondary prevention measures [9].
In the elderly population, syncope can be a particularly important sentinel event for silent MI, presenting unique diagnostic and management challenges due to atypical presentations [10].
Syncope, a transient and self-limiting loss of consciousness, is a common clinical presentation that often necessitates a thorough investigation to identify its underlying cause. While many cases are benign, a significant proportion can be indicative of serious underlying pathology, particularly cardiac conditions. Among these, silent myocardial infarction (MI) has emerged as a critical consideration, especially in certain patient demographics, where it may manifest without the typical anginal symptoms [1].
Recognizing syncope as a potential harbinger of cardiac ischemia, even in the absence of chest pain, is paramount for timely diagnosis and intervention [2].
The diagnostic landscape of syncope is complex, and the focus on identifying cardiac etiologies remains a cornerstone of effective patient management [6].
This is particularly true when considering acute coronary syndromes, where syncope can be the sole or predominant symptom, posing significant diagnostic challenges [3].
Furthermore, specific types of MI, such as non-ST-elevation myocardial infarction (NSTEMI), can present atypically with syncope, underscoring the need for comprehensive cardiac workups [4].
The evaluation of unexplained syncope must include a high index of suspicion for silent MI, especially in individuals with pre-existing cardiovascular risk factors, as it can be a consequence of silent myocardial ischemia [5].
The prevalence and prognostic significance of silent MI in patients with unexplained syncope highlight the necessity of a thorough cardiac assessment, irrespective of the presence of typical anginal symptoms [5].
Moreover, myocardial infarction with non-obstructive coronary arteries (MINOCA) can also present with syncope, demanding its inclusion in the differential diagnosis when initial evaluations are inconclusive [7].
Risk stratification in patients experiencing syncope is crucial for identifying those at high risk of cardiac causes, including silent MI, guiding subsequent diagnostic strategies [8].
The management of silent MI, while differing from overt MI, carries significant prognostic implications, necessitating aggressive secondary prevention measures [9].
In the elderly population, syncope can be a particularly important sentinel event for silent MI, presenting unique diagnostic and management challenges due to atypical presentations [10].
Syncope, a transient and self-limiting loss of consciousness, is a common clinical presentation that often necessitates a thorough investigation to identify its underlying cause. While many cases are benign, a significant proportion can be indicative of serious underlying pathology, particularly cardiac conditions. Among these, silent myocardial infarction (MI) has emerged as a critical consideration, especially in certain patient demographics, where it may manifest without the typical anginal symptoms [1].
Recognizing syncope as a potential harbinger of cardiac ischemia, even in the absence of chest pain, is paramount for timely diagnosis and intervention [2].
The diagnostic landscape of syncope is complex, and the focus on identifying cardiac etiologies remains a cornerstone of effective patient management [6].
This is particularly true when considering acute coronary syndromes, where syncope can be the sole or predominant symptom, posing significant diagnostic challenges [3].
Furthermore, specific types of MI, such as non-ST-elevation myocardial infarction (NSTEMI), can present atypically with syncope, underscoring the need for comprehensive cardiac workups [4].
The evaluation of unexplained syncope must include a high index of suspicion for silent MI, especially in individuals with pre-existing cardiovascular risk factors, as it can be a consequence of silent myocardial ischemia [5].
The prevalence and prognostic significance of silent MI in patients with unexplained syncope highlight the necessity of a thorough cardiac assessment, irrespective of the presence of typical anginal symptoms [5].
Moreover, myocardial infarction with non-obstructive coronary arteries (MINOCA) can also present with syncope, demanding its inclusion in the differential diagnosis when initial evaluations are inconclusive [7].
Risk stratification in patients experiencing syncope is crucial for identifying those at high risk of cardiac causes, including silent MI, guiding subsequent diagnostic strategies [8].
The management of silent MI, while differing from overt MI, carries significant prognostic implications, necessitating aggressive secondary prevention measures [9].
In the elderly population, syncope can be a particularly important sentinel event for silent MI, presenting unique diagnostic and management challenges due to atypical presentations [10].
Syncope, a transient and self-limiting loss of consciousness, is a common clinical presentation that often necessitates a thorough investigation to identify its underlying cause. While many cases are benign, a significant proportion can be indicative of serious underlying pathology, particularly cardiac conditions. Among these, silent myocardial infarction (MI) has emerged as a critical consideration, especially in certain patient demographics, where it may manifest without the typical anginal symptoms [1].
Recognizing syncope as a potential harbinger of cardiac ischemia, even in the absence of chest pain, is paramount for timely diagnosis and intervention [2].
The diagnostic landscape of syncope is complex, and the focus on identifying cardiac etiologies remains a cornerstone of effective patient management [6].
This is particularly true when considering acute coronary syndromes, where syncope can be the sole or predominant symptom, posing significant diagnostic challenges [3].
Furthermore, specific types of MI, such as non-ST-elevation myocardial infarction (NSTEMI), can present atypically with syncope, underscoring the need for comprehensive cardiac workups [4].
The evaluation of unexplained syncope must include a high index of suspicion for silent MI, especially in individuals with pre-existing cardiovascular risk factors, as it can be a consequence of silent myocardial ischemia [5].
The prevalence and prognostic significance of silent MI in patients with unexplained syncope highlight the necessity of a thorough cardiac assessment, irrespective of the presence of typical anginal symptoms [5].
Moreover, myocardial infarction with non-obstructive coronary arteries (MINOCA) can also present with syncope, demanding its inclusion in the differential diagnosis when initial evaluations are inconclusive [7].
Risk stratification in patients experiencing syncope is crucial for identifying those at high risk of cardiac causes, including silent MI, guiding subsequent diagnostic strategies [8].
The management of silent MI, while differing from overt MI, carries significant prognostic implications, necessitating aggressive secondary prevention measures [9].
In the elderly population, syncope can be a particularly important sentinel event for silent MI, presenting unique diagnostic and management challenges due to atypical presentations [10].
Syncope, a transient and self-limiting loss of consciousness, is a common clinical presentation that often necessitates a thorough investigation to identify its underlying cause. While many cases are benign, a significant proportion can be indicative of serious underlying pathology, particularly cardiac conditions. Among these, silent myocardial infarction (MI) has emerged as a critical consideration, especially in certain patient demographics, where it may manifest without the typical anginal symptoms [1].
Recognizing syncope as a potential harbinger of cardiac ischemia, even in the absence of chest pain, is paramount for timely diagnosis and intervention [2].
The diagnostic landscape of syncope is complex, and the focus on identifying cardiac etiologies remains a cornerstone of effective patient management [6].
This is particularly true when considering acute coronary syndromes, where syncope can be the sole or predominant symptom, posing significant diagnostic challenges [3].
Furthermore, specific types of MI, such as non-ST-elevation myocardial infarction (NSTEMI), can present atypically with syncope, underscoring the need for comprehensive cardiac workups [4].
The evaluation of unexplained syncope must include a high index of suspicion for silent MI, especially in individuals with pre-existing cardiovascular risk factors, as it can be a consequence of silent myocardial ischemia [5].
The prevalence and prognostic significance of silent MI in patients with unexplained syncope highlight the necessity of a thorough cardiac assessment, irrespective of the presence of typical anginal symptoms [5].
Moreover, myocardial infarction with non-obstructive coronary arteries (MINOCA) can also present with syncope, demanding its inclusion in the differential diagnosis when initial evaluations are inconclusive [7].
Risk stratification in patients experiencing syncope is crucial for identifying those at high risk of cardiac causes, including silent MI, guiding subsequent diagnostic strategies [8].
The management of silent MI, while differing from overt MI, carries significant prognostic implications, necessitating aggressive secondary prevention measures [9].
In the elderly population, syncope can be a particularly important sentinel event for silent MI, presenting unique diagnostic and management challenges due to atypical presentations [10].
Syncope, a transient and self-limiting loss of consciousness, is a common clinical presentation that often necessitates a thorough investigation to identify its underlying cause. While many cases are benign, a significant proportion can be indicative of serious underlying pathology, particularly cardiac conditions. Among these, silent myocardial infarction (MI) has emerged as a critical consideration, especially in certain patient demographics, where it may manifest without the typical anginal symptoms [1].
Recognizing syncope as a potential harbinger of cardiac ischemia, even in the absence of chest pain, is paramount for timely diagnosis and intervention [2].
The diagnostic landscape of syncope is complex, and the focus on identifying cardiac etiologies remains a cornerstone of effective patient management [6].
This is particularly true when considering acute coronary syndromes, where syncope can be the sole or predominant symptom, posing significant diagnostic challenges [3].
Furthermore, specific types of MI, such as non-ST-elevation myocardial infarction (NSTEMI), can present atypically with syncope, underscoring the need for comprehensive cardiac workups [4].
The evaluation of unexplained syncope must include a high index of suspicion for silent MI, especially in individuals with pre-existing cardiovascular risk factors, as it can be a consequence of silent myocardial ischemia [5].
The prevalence and prognostic significance of silent MI in patients with unexplained syncope highlight the necessity of a thorough cardiac assessment, irrespective of the presence of typical anginal symptoms [5].
Moreover, myocardial infarction with non-obstructive coronary arteries (MINOCA) can also present with syncope, demanding its inclusion in the differential diagnosis when initial evaluations are inconclusive [7].
Risk stratification in patients experiencing syncope is crucial for identifying those at high risk of cardiac causes, including silent MI, guiding subsequent diagnostic strategies [8].
The management of silent MI, while differing from overt MI, carries significant prognostic implications, necessitating aggressive secondary prevention measures [9].
In the elderly population, syncope can be a particularly important sentinel event for silent MI, presenting unique diagnostic and management challenges due to atypical presentations [10].
Syncope, a transient and self-limiting loss of consciousness, is a common clinical presentation that often necessitates a thorough investigation to identify its underlying cause. While many cases are benign, a significant proportion can be indicative of serious underlying pathology, particularly cardiac conditions. Among these, silent myocardial infarction (MI) has emerged as a critical consideration, especially in certain patient demographics, where it may manifest without the typical anginal symptoms [1].
Recognizing syncope as a potential harbinger of cardiac ischemia, even in the absence of chest pain, is paramount for timely diagnosis and intervention [2].
The diagnostic landscape of syncope is complex, and the focus on identifying cardiac etiologies remains a cornerstone of effective patient management [6].
This is particularly true when considering acute coronary syndromes, where syncope can be the sole or predominant symptom, posing significant diagnostic challenges [3].
Furthermore, specific types of MI, such as non-ST-elevation myocardial infarction (NSTEMI), can present atypically with syncope, underscoring the need for comprehensive cardiac workups [4].
The evaluation of unexplained syncope must include a high index of suspicion for silent MI, especially in individuals with pre-existing cardiovascular risk factors, as it can be a consequence of silent myocardial ischemia [5].
The prevalence and prognostic significance of silent MI in patients with unexplained syncope highlight the necessity of a thorough cardiac assessment, irrespective of the presence of typical anginal symptoms [5].
Moreover, myocardial infarction with non-obstructive coronary arteries (MINOCA) can also present with syncope, demanding its inclusion in the differential diagnosis when initial evaluations are inconclusive [7].
Risk stratification in patients experiencing syncope is crucial for identifying those at high risk of cardiac causes, including silent MI, guiding subsequent diagnostic strategies [8].
The management of silent MI, while differing from overt MI, carries significant prognostic implications, necessitating aggressive secondary prevention measures [9].
In the elderly population, syncope can be a particularly important sentinel event for silent MI, presenting unique diagnostic and management challenges due to atypical presentations [10].
A case report illustrates a middle-aged individual experiencing syncope, which was determined to be a consequence of a silent myocardial infarction (MI). This case underscores the critical importance of considering cardiac ischemia as a cause of syncope, even without the presence of classic chest pain, particularly in this age group. Prompt recognition and appropriate medical management are essential to prevent future cardiovascular events [1].
Unmasking silent myocardial infarction through atypical presentations like syncope is a crucial clinical endeavor. This study highlights that a considerable number of MIs may not present with classic symptoms, especially in specific patient populations. Therefore, a comprehensive diagnostic evaluation, including serial electrocardiograms (ECGs) and cardiac biomarkers, is indispensable to avoid misdiagnosis and ensure timely treatment [2].
Syncope can be the sole or primary symptom of acute coronary syndrome, which can be diagnostically misleading. This research delves into the diagnostic complexities and outcomes associated with syncope in patients suspected of or confirmed to have cardiac ischemia. It emphasizes the necessity of maintaining a high index of suspicion for silent MI in patients presenting with syncope, particularly those with existing cardiovascular risk factors [3].
The role of non-ST-elevation myocardial infarction (NSTEMI) in precipitating syncope is frequently underestimated. This review examines the underlying pathophysiology and clinical manifestations of NSTEMI, with a specific focus on its presentation as syncope. It stresses the significance of advanced cardiac imaging and rigorous risk stratification in identifying patients with silent NSTEMI [4].
Silent myocardial ischemia can occur in various clinical scenarios, and syncope is a potential sequela. This prospective study evaluates the incidence and predictors of silent MI in individuals presenting with unexplained syncope. The findings suggest that a comprehensive cardiac assessment is warranted for all patients experiencing syncope, irrespective of whether they exhibit typical anginal symptoms [5].
Identifying cardiac causes of syncope is of utmost importance for guiding appropriate patient management. This article reviews the differential diagnoses of syncope, with a particular emphasis on cardiac etiologies, including silent MI. It highlights the crucial role of electrophysiology studies and cardiac imaging in determining the definitive cause of syncope [6].
Myocardial infarction with non-obstructive coronary arteries (MINOCA) can also manifest with atypical symptoms, including syncope. This study investigates MINOCA cases that presented predominantly with syncope, emphasizing the need to consider MINOCA in the differential diagnosis of syncope, especially when initial coronary angiography results are normal [7].
Risk stratification for cardiovascular events in patients who have experienced syncope is a critical aspect of patient care. This paper examines various risk scores and diagnostic approaches designed to identify individuals at high risk for cardiac causes of syncope, including silent MI. It advocates for a structured, stepwise approach to diagnosis [8].
The management strategies for silent MI differ from those for overt MI, yet the long-term prognostic implications can be equally severe. This study discusses current therapeutic interventions and long-term outcomes for patients diagnosed with silent MI, underscoring the importance of secondary prevention measures to mitigate the risk of future cardiovascular events and enhance quality of life [9].
The elderly population often presents with atypical manifestations of cardiovascular diseases. This article focuses on syncope as a potential early warning sign for silent MI in older adults. It highlights the diagnostic challenges and the necessity of tailored management strategies for this particularly vulnerable patient group [10].
A case report illustrates a middle-aged individual experiencing syncope, which was determined to be a consequence of a silent myocardial infarction (MI). This case underscores the critical importance of considering cardiac ischemia as a cause of syncope, even without the presence of classic chest pain, particularly in this age group. Prompt recognition and appropriate medical management are essential to prevent future cardiovascular events [1].
Unmasking silent myocardial infarction through atypical presentations like syncope is a crucial clinical endeavor. This study highlights that a considerable number of MIs may not present with classic symptoms, especially in specific patient populations. Therefore, a comprehensive diagnostic evaluation, including serial electrocardiograms (ECGs) and cardiac biomarkers, is indispensable to avoid misdiagnosis and ensure timely treatment [2].
Syncope can be the sole or primary symptom of acute coronary syndrome, which can be diagnostically misleading. This research delves into the diagnostic complexities and outcomes associated with syncope in patients suspected of or confirmed to have cardiac ischemia. It emphasizes the necessity of maintaining a high index of suspicion for silent MI in patients presenting with syncope, particularly those with existing cardiovascular risk factors [3].
The role of non-ST-elevation myocardial infarction (NSTEMI) in precipitating syncope is frequently underestimated. This review examines the underlying pathophysiology and clinical manifestations of NSTEMI, with a specific focus on its presentation as syncope. It stresses the significance of advanced cardiac imaging and rigorous risk stratification in identifying patients with silent NSTEMI [4].
Silent myocardial ischemia can occur in various clinical scenarios, and syncope is a potential sequela. This prospective study evaluates the incidence and predictors of silent MI in individuals presenting with unexplained syncope. The findings suggest that a comprehensive cardiac assessment is warranted for all patients experiencing syncope, irrespective of whether they exhibit typical anginal symptoms [5].
Identifying cardiac causes of syncope is of utmost importance for guiding appropriate patient management. This article reviews the differential diagnoses of syncope, with a particular emphasis on cardiac etiologies, including silent MI. It highlights the crucial role of electrophysiology studies and cardiac imaging in determining the definitive cause of syncope [6].
Myocardial infarction with non-obstructive coronary arteries (MINOCA) can also manifest with atypical symptoms, including syncope. This study investigates MINOCA cases that presented predominantly with syncope, emphasizing the need to consider MINOCA in the differential diagnosis of syncope, especially when initial coronary angiography results are normal [7].
Risk stratification for cardiovascular events in patients who have experienced syncope is a critical aspect of patient care. This paper examines various risk scores and diagnostic approaches designed to identify individuals at high risk for cardiac causes of syncope, including silent MI. It advocates for a structured, stepwise approach to diagnosis [8].
The management strategies for silent MI differ from those for overt MI, yet the long-term prognostic implications can be equally severe. This study discusses current therapeutic interventions and long-term outcomes for patients diagnosed with silent MI, underscoring the importance of secondary prevention measures to mitigate the risk of future cardiovascular events and enhance quality of life [9].
The elderly population often presents with atypical manifestations of cardiovascular diseases. This article focuses on syncope as a potential early warning sign for silent MI in older adults. It highlights the diagnostic challenges and the necessity of tailored management strategies for this particularly vulnerable patient group [10].
A case report illustrates a middle-aged individual experiencing syncope, which was determined to be a consequence of a silent myocardial infarction (MI). This case underscores the critical importance of considering cardiac ischemia as a cause of syncope, even without the presence of classic chest pain, particularly in this age group. Prompt recognition and appropriate medical management are essential to prevent future cardiovascular events [1].
Unmasking silent myocardial infarction through atypical presentations like syncope is a crucial clinical endeavor. This study highlights that a considerable number of MIs may not present with classic symptoms, especially in specific patient populations. Therefore, a comprehensive diagnostic evaluation, including serial electrocardiograms (ECGs) and cardiac biomarkers, is indispensable to avoid misdiagnosis and ensure timely treatment [2].
Syncope can be the sole or primary symptom of acute coronary syndrome, which can be diagnostically misleading. This research delves into the diagnostic complexities and outcomes associated with syncope in patients suspected of or confirmed to have cardiac ischemia. It emphasizes the necessity of maintaining a high index of suspicion for silent MI in patients presenting with syncope, particularly those with existing cardiovascular risk factors [3].
The role of non-ST-elevation myocardial infarction (NSTEMI) in precipitating syncope is frequently underestimated. This review examines the underlying pathophysiology and clinical manifestations of NSTEMI, with a specific focus on its presentation as syncope. It stresses the significance of advanced cardiac imaging and rigorous risk stratification in identifying patients with silent NSTEMI [4].
Silent myocardial ischemia can occur in various clinical scenarios, and syncope is a potential sequela. This prospective study evaluates the incidence and predictors of silent MI in individuals presenting with unexplained syncope. The findings suggest that a comprehensive cardiac assessment is warranted for all patients experiencing syncope, irrespective of whether they exhibit typical anginal symptoms [5].
Identifying cardiac causes of syncope is of utmost importance for guiding appropriate patient management. This article reviews the differential diagnoses of syncope, with a particular emphasis on cardiac etiologies, including silent MI. It highlights the crucial role of electrophysiology studies and cardiac imaging in determining the definitive cause of syncope [6].
Myocardial infarction with non-obstructive coronary arteries (MINOCA) can also manifest with atypical symptoms, including syncope. This study investigates MINOCA cases that presented predominantly with syncope, emphasizing the need to consider MINOCA in the differential diagnosis of syncope, especially when initial coronary angiography results are normal [7].
Risk stratification for cardiovascular events in patients who have experienced syncope is a critical aspect of patient care. This paper examines various risk scores and diagnostic approaches designed to identify individuals at high risk for cardiac causes of syncope, including silent MI. It advocates for a structured, stepwise approach to diagnosis [8].
The management strategies for silent MI differ from those for overt MI, yet the long-term prognostic implications can be equally severe. This study discusses current therapeutic interventions and long-term outcomes for patients diagnosed with silent MI, underscoring the importance of secondary prevention measures to mitigate the risk of future cardiovascular events and enhance quality of life [9].
The elderly population often presents with atypical manifestations of cardiovascular diseases. This article focuses on syncope as a potential early warning sign for silent MI in older adults. It highlights the diagnostic challenges and the necessity of tailored management strategies for this particularly vulnerable patient group [10].
A case report illustrates a middle-aged individual experiencing syncope, which was determined to be a consequence of a silent myocardial infarction (MI). This case underscores the critical importance of considering cardiac ischemia as a cause of syncope, even without the presence of classic chest pain, particularly in this age group. Prompt recognition and appropriate medical management are essential to prevent future cardiovascular events [1].
Unmasking silent myocardial infarction through atypical presentations like syncope is a crucial clinical endeavor. This study highlights that a considerable number of MIs may not present with classic symptoms, especially in specific patient populations. Therefore, a comprehensive diagnostic evaluation, including serial electrocardiograms (ECGs) and cardiac biomarkers, is indispensable to avoid misdiagnosis and ensure timely treatment [2].
Syncope can be the sole or primary symptom of acute coronary syndrome, which can be diagnostically misleading. This research delves into the diagnostic complexities and outcomes associated with syncope in patients suspected of or confirmed to have cardiac ischemia. It emphasizes the necessity of maintaining a high index of suspicion for silent MI in patients presenting with syncope, particularly those with existing cardiovascular risk factors [3].
The role of non-ST-elevation myocardial infarction (NSTEMI) in precipitating syncope is frequently underestimated. This review examines the underlying pathophysiology and clinical manifestations of NSTEMI, with a specific focus on its presentation as syncope. It stresses the significance of advanced cardiac imaging and rigorous risk stratification in identifying patients with silent NSTEMI [4].
Silent myocardial ischemia can occur in various clinical scenarios, and syncope is a potential sequela. This prospective study evaluates the incidence and predictors of silent MI in individuals presenting with unexplained syncope. The findings suggest that a comprehensive cardiac assessment is warranted for all patients experiencing syncope, irrespective of whether they exhibit typical anginal symptoms [5].
Identifying cardiac causes of syncope is of utmost importance for guiding appropriate patient management. This article reviews the differential diagnoses of syncope, with a particular emphasis on cardiac etiologies, including silent MI. It highlights the crucial role of electrophysiology studies and cardiac imaging in determining the definitive cause of syncope [6].
Myocardial infarction with non-obstructive coronary arteries (MINOCA) can also manifest with atypical symptoms, including syncope. This study investigates MINOCA cases that presented predominantly with syncope, emphasizing the need to consider MINOCA in the differential diagnosis of syncope, especially when initial coronary angiography results are normal [7].
Risk stratification for cardiovascular events in patients who have experienced syncope is a critical aspect of patient care. This paper examines various risk scores and diagnostic approaches designed to identify individuals at high risk for cardiac causes of syncope, including silent MI. It advocates for a structured, stepwise approach to diagnosis [8].
The management strategies for silent MI differ from those for overt MI, yet the long-term prognostic implications can be equally severe. This study discusses current therapeutic interventions and long-term outcomes for patients diagnosed with silent MI, underscoring the importance of secondary prevention measures to mitigate the risk of future cardiovascular events and enhance quality of life [9].
The elderly population often presents with atypical manifestations of cardiovascular diseases. This article focuses on syncope as a potential early warning sign for silent MI in older adults. It highlights the diagnostic challenges and the necessity of tailored management strategies for this particularly vulnerable patient group [10].
A case report illustrates a middle-aged individual experiencing syncope, which was determined to be a consequence of a silent myocardial infarction (MI). This case underscores the critical importance of considering cardiac ischemia as a cause of syncope, even without the presence of classic chest pain, particularly in this age group. Prompt recognition and appropriate medical management are essential to prevent future cardiovascular events [1].
Unmasking silent myocardial infarction through atypical presentations like syncope is a crucial clinical endeavor. This study highlights that a considerable number of MIs may not present with classic symptoms, especially in specific patient populations. Therefore, a comprehensive diagnostic evaluation, including serial electrocardiograms (ECGs) and cardiac biomarkers, is indispensable to avoid misdiagnosis and ensure timely treatment [2].
Syncope can be the sole or primary symptom of acute coronary syndrome, which can be diagnostically misleading. This research delves into the diagnostic complexities and outcomes associated with syncope in patients suspected of or confirmed to have cardiac ischemia. It emphasizes the necessity of maintaining a high index of suspicion for silent MI in patients presenting with syncope, particularly those with existing cardiovascular risk factors [3].
The role of non-ST-elevation myocardial infarction (NSTEMI) in precipitating syncope is frequently underestimated. This review examines the underlying pathophysiology and clinical manifestations of NSTEMI, with a specific focus on its presentation as syncope. It stresses the significance of advanced cardiac imaging and rigorous risk stratification in identifying patients with silent NSTEMI [4].
Silent myocardial ischemia can occur in various clinical scenarios, and syncope is a potential sequela. This prospective study evaluates the incidence and predictors of silent MI in individuals presenting with unexplained syncope. The findings suggest that a comprehensive cardiac assessment is warranted for all patients experiencing syncope, irrespective of whether they exhibit typical anginal symptoms [5].
Identifying cardiac causes of syncope is of utmost importance for guiding appropriate patient management. This article reviews the differential diagnoses of syncope, with a particular emphasis on cardiac etiologies, including silent MI. It highlights the crucial role of electrophysiology studies and cardiac imaging in determining the definitive cause of syncope [6].
Myocardial infarction with non-obstructive coronary arteries (MINOCA) can also manifest with atypical symptoms, including syncope. This study investigates MINOCA cases that presented predominantly with syncope, emphasizing the need to consider MINOCA in the differential diagnosis of syncope, especially when initial coronary angiography results are normal [7].
Risk stratification for cardiovascular events in patients who have experienced syncope is a critical aspect of patient care. This paper examines various risk scores and diagnostic approaches designed to identify individuals at high risk for cardiac causes of syncope, including silent MI. It advocates for a structured, stepwise approach to diagnosis [8].
The management strategies for silent MI differ from those for overt MI, yet the long-term prognostic implications can be equally severe. This study discusses current therapeutic interventions and long-term outcomes for patients diagnosed with silent MI, underscoring the importance of secondary prevention measures to mitigate the risk of future cardiovascular events and enhance quality of life [9].
The elderly population often presents with atypical manifestations of cardiovascular diseases. This article focuses on syncope as a potential early warning sign for silent MI in older adults. It highlights the diagnostic challenges and the necessity of tailored management strategies for this particularly vulnerable patient group [10].
A case report illustrates a middle-aged individual experiencing syncope, which was determined to be a consequence of a silent myocardial infarction (MI). This case underscores the critical importance of considering cardiac ischemia as a cause of syncope, even without the presence of classic chest pain, particularly in this age group. Prompt recognition and appropriate medical management are essential to prevent future cardiovascular events [1].
Unmasking silent myocardial infarction through atypical presentations like syncope is a crucial clinical endeavor. This study highlights that a considerable number of MIs may not present with classic symptoms, especially in specific patient populations. Therefore, a comprehensive diagnostic evaluation, including serial electrocardiograms (ECGs) and cardiac biomarkers, is indispensable to avoid misdiagnosis and ensure timely treatment [2].
Syncope can be the sole or primary symptom of acute coronary syndrome, which can be diagnostically misleading. This research delves into the diagnostic complexities and outcomes associated with syncope in patients suspected of or confirmed to have cardiac ischemia. It emphasizes the necessity of maintaining a high index of suspicion for silent MI in patients presenting with syncope, particularly those with existing cardiovascular risk factors [3].
The role of non-ST-elevation myocardial infarction (NSTEMI) in precipitating syncope is frequently underestimated. This review examines the underlying pathophysiology and clinical manifestations of NSTEMI, with a specific focus on its presentation as syncope. It stresses the significance of advanced cardiac imaging and rigorous risk stratification in identifying patients with silent NSTEMI [4].
Silent myocardial ischemia can occur in various clinical scenarios, and syncope is a potential sequela. This prospective study evaluates the incidence and predictors of silent MI in individuals presenting with unexplained syncope. The findings suggest that a comprehensive cardiac assessment is warranted for all patients experiencing syncope, irrespective of whether they exhibit typical anginal symptoms [5].
Identifying cardiac causes of syncope is of utmost importance for guiding appropriate patient management. This article reviews the differential diagnoses of syncope, with a particular emphasis on cardiac etiologies, including silent MI. It highlights the crucial role of electrophysiology studies and cardiac imaging in determining the definitive cause of syncope [6].
Myocardial infarction with non-obstructive coronary arteries (MINOCA) can also manifest with atypical symptoms, including syncope. This study investigates MINOCA cases that presented predominantly with syncope, emphasizing the need to consider MINOCA in the differential diagnosis of syncope, especially when initial coronary angiography results are normal [7].
Risk stratification for cardiovascular events in patients who have experienced syncope is a critical aspect of patient care. This paper examines various risk scores and diagnostic approaches designed to identify individuals at high risk for cardiac causes of syncope, including silent MI. It advocates for a structured, stepwise approach to diagnosis [8].
The management strategies for silent MI differ from those for overt MI, yet the long-term prognostic implications can be equally severe. This study discusses current therapeutic interventions and long-term outcomes for patients diagnosed with silent MI, underscoring the importance of secondary prevention measures to mitigate the risk of future cardiovascular events and enhance quality of life [9].
The elderly population often presents with atypical manifestations of cardiovascular diseases. This article focuses on syncope as a potential early warning sign for silent MI in older adults. It highlights the diagnostic challenges and the necessity of tailored management strategies for this particularly vulnerable patient group [10].
A case report illustrates a middle-aged individual experiencing syncope, which was determined to be a consequence of a silent myocardial infarction (MI). This case underscores the critical importance of considering cardiac ischemia as a cause of syncope, even without the presence of classic chest pain, particularly in this age group. Prompt recognition and appropriate medical management are essential to prevent future cardiovascular events [1].
Unmasking silent myocardial infarction through atypical presentations like syncope is a crucial clinical endeavor. This study highlights that a considerable number of MIs may not present with classic symptoms, especially in specific patient populations. Therefore, a comprehensive diagnostic evaluation, including serial electrocardiograms (ECGs) and cardiac biomarkers, is indispensable to avoid misdiagnosis and ensure timely treatment [2].
Syncope can be the sole or primary symptom of acute coronary syndrome, which can be diagnostically misleading. This research delves into the diagnostic complexities and outcomes associated with syncope in patients suspected of or confirmed to have cardiac ischemia. It emphasizes the necessity of maintaining a high index of suspicion for silent MI in patients presenting with syncope, particularly those with existing cardiovascular risk factors [3].
The role of non-ST-elevation myocardial infarction (NSTEMI) in precipitating syncope is frequently underestimated. This review examines the underlying pathophysiology and clinical manifestations of NSTEMI, with a specific focus on its presentation as syncope. It stresses the significance of advanced cardiac imaging and rigorous risk stratification in identifying patients with silent NSTEMI [4].
Silent myocardial ischemia can occur in various clinical scenarios, and syncope is a potential sequela. This prospective study evaluates the incidence and predictors of silent MI in individuals presenting with unexplained syncope. The findings suggest that a comprehensive cardiac assessment is warranted for all patients experiencing syncope, irrespective of whether they exhibit typical anginal symptoms [5].
Identifying cardiac causes of syncope is of utmost importance for guiding appropriate patient management. This article reviews the differential diagnoses of syncope, with a particular emphasis on cardiac etiologies, including silent MI. It highlights the crucial role of electrophysiology studies and cardiac imaging in determining the definitive cause of syncope [6].
Myocardial infarction with non-obstructive coronary arteries (MINOCA) can also manifest with atypical symptoms, including syncope. This study investigates MINOCA cases that presented predominantly with syncope, emphasizing the need to consider MINOCA in the differential diagnosis of syncope, especially when initial coronary angiography results are normal [7].
Risk stratification for cardiovascular events in patients who have experienced syncope is a critical aspect of patient care. This paper examines various risk scores and diagnostic approaches designed to identify individuals at high risk for cardiac causes of syncope, including silent MI. It advocates for a structured, stepwise approach to diagnosis [8].
The management strategies for silent MI differ from those for overt MI, yet the long-term prognostic implications can be equally severe. This study discusses current therapeutic interventions and long-term outcomes for patients diagnosed with silent MI, underscoring the importance of secondary prevention measures to mitigate the risk of future cardiovascular events and enhance quality of life [9].
The elderly population often presents with atypical manifestations of cardiovascular diseases. This article focuses on syncope as a potential early warning sign for silent MI in older adults. It highlights the diagnostic challenges and the necessity of tailored management strategies for this particularly vulnerable patient group [10].
Syncope, or transient loss of consciousness, can be a manifestation of a silent myocardial infarction (MI), particularly in middle-aged individuals. This highlights the importance of considering cardiac ischemia even without typical chest pain. Atypical presentations of MI are common, necessitating thorough diagnostic workups including ECGs and cardiac biomarkers. Syncope as the sole symptom of acute coronary syndromes poses diagnostic challenges, and a high index of suspicion for silent MI is crucial, especially in those with cardiovascular risk factors. Non-ST-elevation MI and MINOCA can also present as syncope, requiring advanced imaging and risk stratification. Comprehensive cardiac evaluation is vital for unexplained syncope. While management of silent MI differs from overt MI, secondary prevention is key. Elderly individuals with syncope may have atypical presentations of silent MI, requiring tailored management.
None
None
Journal of Clinical Case Reports received 1345 citations as per Google Scholar report
